In case the failure to satisfy CGMP brings about the distribution of the drug that doesn't give the benefit as labeled for the reason that, by way of example, it's way too very little active ingredient, the organization may possibly subsequently remember that products.="" in="" accordance="" with="" the="" regulatory="" versatility="" act,="" fda="